Major EU Market Countries definition

Major EU Market Countries means [*].
Major EU Market Countries means Germany, the United Kingdom, Spain, Italy and France.
Major EU Market Countries means [**].

Examples of Major EU Market Countries in a sentence

  • Lessor may apply any portion of the Security Deposit to any Rent or other amount under this Lease which is not paid when due or to any damage suffered by Lessor as a result of any breach of Lessee, all without prejudice to any other remedy of Lessor under this Lease, at law, or at equity.

  • Pfizer’s rights with respect to an Enforcement Action for BioNTech Enforcement Patent Rights other than Product Patent Rights shall be limited to (i) Major Market Countries; (ii) Enforcement Actions in countries in which a Competitive Product (or part thereof) reasonably believed to be designated for any Major Market Country is Manufactured; and (iii) Enforcement Actions in Belgium, Ireland or the Netherlands that are in parallel with Enforcement Actions in any of the Major EU Market Countries.

  • Xxxxx Xxxxxxx Xxxxxxxxx in accordance with the License Development Plan and/or License Commercialization Plan, and (2) in the China Territory, and (B) if Juno has exercised the Commercialization Opt-In Right pursuant to Section 3.3.1, for Juno to conduct Commercialization Activities that are [***] for ROW Territory Administration in the Major EU Market Countries.

  • The foregoing termination right shall cease to apply after [*] has been commercially launched in [*] of the Major EU Market Countries.

  • If [***] for the North America Territory or the Major EU Market Countries, then [***] will have the right to [***] until such time as [***], and, for clarity, all costs incurred by [***] related to [***].

  • Each Party shall engage sales representatives having the minimum qualifications set forth in Schedule 3.1.6(b), provided that if Juno has exercised its right to co-Commercialize in the Major EU Market Countries pursuant to Sections 3.1.2 and/or 3.1.3, the sales representatives [***].

  • Product has received Regulatory Approval from the EMA or the FDA, as applicable, or at such other time as the JCC deems appropriate, and for the remainder of the License Term for such Licensed Product, setting forth the number of details made by its sales representatives of Licensed Product in the Major EU Market Countries during such Calendar Quarter.

  • Prior to its expiration, this Agreement may be terminated in its entirety or on a Product-by-Product and/or country-by-country basis, in its sole discretion, at any time by SpePharm effective upon at least one hundred and eighty (180) days’ prior written notice to Company for any reason; provided however, if SpePharm terminates this Agreement, whether in whole or in part, in any of the Major EU Market Countries, such termination shall be deemed a termination of this Agreement in its entirety.


More Definitions of Major EU Market Countries

Major EU Market Countries means any of the following countries: [***].
Major EU Market Countries means [*].[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities andExchange Commission pursuant to rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Related to Major EU Market Countries

  • Major Market Countries means the United States, Japan, England, Germany, France, Italy and Spain.

  • Major Market Country means each of the United States, Japan, France, Germany, Italy, Spain and the United Kingdom.

  • Major EU Country Major EU Country means France, Germany, Italy, Spain or the United Kingdom.

  • Major European Countries means France, Germany, Italy, Spain and the United Kingdom.

  • Major Market means any one of the following countries: United States, Japan, the United Kingdom, France, Germany, Italy or Spain.

  • Major Markets means [***].

  • Major European Country means any of France, Germany, Italy, Spain or the United Kingdom.

  • Major Countries means Canada, France, Germany, Italy, Japan, Spain, United Kingdom and the United States.

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Selected Countries the jurisdictions listed on Appendix C as such may be amended from time to time in accordance with Article II.

  • Marketing Approval means all approvals, licenses, registrations or authorizations of the Regulatory Authority in a country, necessary for the manufacture, use, storage, import, marketing and sale of a Product in such country.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Designated country end product means a WTO GPA country end product, a Free Trade Agreement country end product, a least developed country end product, or a Caribbean Basin country end product.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • EU GDPR means Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC.

  • NDA Approval means the Approval of an NDA by the FDA for a Product in the U.S.

  • WTO GPA country end product means an article that—

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • customs territory means the territory of the country of each Contracting Party in which the Customs laws of that country are in force;

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • First Indication means the first disease condition for which a particular Licensed Product has been approved by a Regulatory Authority.

  • Major Country means the United States, Japan, France, Germany, Italy, Spain, and the United Kingdom.

  • Host Country means, with respect to an Insured Person, the country or territory the Insured Person is visiting or in which the Insured Person is living, which is not the Insured Person’s Home Country.

  • Orange Book means the FDA publication entitled “Approved Drug Products with Therapeutic Equivalence Evaluations” or any replacement thereof established or approved by the FDA.